Status:
UNKNOWN
Combination Chemotherapy and/or Radiation Therapy in Treating Young Patients With Hodgkin's Lymphoma
Lead Sponsor:
Children's Cancer and Leukaemia Group
Conditions:
Lymphoma
Eligibility:
All Genders
Up to 14 years
Phase:
NA
Brief Summary
RATIONALE: Drugs used in chemotherapy, such as chlorambucil, vinblastine, procarbazine, and prednisolone, work in different ways to stop the growth of cancer cells, either by killing the cells or by s...
Detailed Description
OBJECTIVES: * Establish a uniform practice for the management of children with Hodgkin's lymphoma. * Document the long-term side effects of such management. * Establish whether or not children can be...
Eligibility Criteria
Inclusion
- DISEASE CHARACTERISTICS:
- Biopsy proven Hodgkin's lymphoma
- Any stage allowed
- PATIENT CHARACTERISTICS:
- Not specified
- PRIOR CONCURRENT THERAPY:
- Not specified
Exclusion
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
358 Patients enrolled
Trial Details
Trial ID
NCT00417014
Last Update
August 2 2013
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.